Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Enfield KSS"'
Autor:
Cole M; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Anastasiou P; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK., Yu X; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands., de Castro A; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Roelink J; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Moore C; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Mugarza E; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Jones M; Electron Microscopy, Francis Crick Institute, London, UK., Valand K; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Rana S; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK., Enfield KSS; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK., Magness A; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK., Mullokandov A; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Kelly G; Bioinformatics and Biostatistics, Francis Crick Institute, London, UK., de Gruijl TD; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands.; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Molina-Arcas M; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Downward J; Oncogene Biology Laboratory, Francis Crick Institute, London, UK., van Maldegem F; Oncogene Biology Laboratory, Francis Crick Institute, London, UK.; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands.
Publikováno v:
Science advances [Sci Adv] 2024 Nov; Vol. 10 (44), pp. eadl6464. Date of Electronic Publication: 2024 Nov 01.
Autor:
Magness A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. alastair.magness@crick.ac.uk., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Shimato M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Daly E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Valand K; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Levi D; Flow Cytometry, The Francis Crick Institute, London, UK., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hobson PS; Flow Cytometry, The Francis Crick Institute, London, UK., van Maldegem F; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands., Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Pre-cancer Immunology Laboratory, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research, Department of Haematology, University College London Cancer Institute, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research, Department of Haematology, University College London Cancer Institute, London, UK., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. mihaela.angelova@crick.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 15; Vol. 15 (1), pp. 5135. Date of Electronic Publication: 2024 Jun 15.
Autor:
Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Magness A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom., Hobson PS; Flow Cytometry, The Francis Crick Institute, London, United Kingdom., Levi D; Flow Cytometry, The Francis Crick Institute, London, United Kingdom., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Nye EL; Experimental Histopathology, The Francis Crick Institute, London, United Kingdom., Green M; Experimental Histopathology, The Francis Crick Institute, London, United Kingdom., Dijkstra KK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Shimato M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Akarca AU; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Hackshaw A; Cancer Research UK and University College London Cancer Trials Centre, London, United Kingdom., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom., van Maldegem F; Oncogene Biology Laboratory, The Francis Crick Institute, London, United Kingdom., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Glass B; PathAI, Inc., Boston, Massachusetts., Pulaski H; PathAI, Inc., Boston, Massachusetts., Walk E; PathAI, Inc., Boston, Massachusetts., Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Pre-cancer Immunology Laboratory, University College London Cancer Institute, London, United Kingdom.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jun 03; Vol. 14 (6), pp. 1018-1047.
Autor:
Zhang H; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., AbdulJabbar K; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Akarca A; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom.; Cancer Metastasis Lab, University College London Cancer Institute, London, United Kingdom., Raza SEA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; NHS Greater Glasgow and Clyde Pathology Department, Queen Elizabeth University Hospital, London, United Kingdom., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Yuan Y; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2023 May 02; Vol. 83 (9), pp. 1410-1425.
Autor:
Ng KW; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK., Boumelha J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Almagro J; Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK., Cha H; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Queensland, Australia., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Young G; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.; Bioinformatics and Biostatistics Facility, The Francis Crick Institute, London, UK., Molina-Arcas M; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Anastasiou P; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Fendler A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Units, The Royal Marsden Hospital, London, UK., Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Units, The Royal Marsden Hospital, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Kim H; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Shim S; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea., Faulkner N; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Attig J; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Magno N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Behrens A; Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK.; Cancer Stem Cell Laboratory, Institute of Cancer Research, London, UK.; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.; CRUK Convergence Science Centre, Imperial College, London, UK., Yousaf N; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Lung Unit, The Royal Marsden Hospital, London, UK., Popat S; Lung Unit, The Royal Marsden Hospital, London, UK.; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Hackshaw A; Cancer Research UK and University College London Cancer Trials Centre, London, UK., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Larkin J; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK. julian.downward@crick.ac.uk., Kassiotis G; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK. george.kassiotis@crick.ac.uk.; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. george.kassiotis@crick.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 563-573. Date of Electronic Publication: 2023 Apr 12.
Autor:
Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Magno N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Bakir MA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Puttick C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Zhai H; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Gimeno-Valiente F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Saghafinia S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Campbell BB; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Cadieux EL; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK., Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Integrative Cancer Genomics Laboratory, Department of Oncology, KU Leuven, Leuven, Belgium.; VIB - KU Leuven Center for Cancer Biology, Leuven, Belgium., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adusumilli PS; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tan KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheema W; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sanchez-Vega F; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jones DR; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rekhtman N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk.
Publikováno v:
Nature medicine [Nat Med] 2023 Apr; Vol. 29 (4), pp. 833-845. Date of Electronic Publication: 2023 Apr 12.
Autor:
Stewart GL; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada., Sage AP; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada., Enfield KSS; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada., Marshall EA; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada., Cohn DE; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada., Lam WL; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.
Publikováno v:
Frontiers in genetics [Front Genet] 2021 Jan 11; Vol. 11, pp. 615378. Date of Electronic Publication: 2021 Jan 11 (Print Publication: 2020).
Autor:
Sage AP; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada., Ng KW; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada., Marshall EA; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. emarshall@bccrc.ca., Stewart GL; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada., Minatel BC; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada., Enfield KSS; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada., Martin SD; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada., Brown CJ; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada., Abraham N; Department of Zoology, University of British Columbia, Vancouver, BC, Canada.; Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada., Lam WL; Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
Publikováno v:
Scientific reports [Sci Rep] 2020 Oct 09; Vol. 10 (1), pp. 16945. Date of Electronic Publication: 2020 Oct 09.
Autor:
Enfield KSS; British Columbia Cancer Research Centre, Vancouver, BC, Canada. katey.enfield@crick.ac.uk., Marshall EA; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Anderson C; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Ng KW; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Rahmati S; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Xu Z; Dalhousie University, Halifax, NS, Canada., Fuller M; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Milne K; Deeley Research Centre, Victoria, BC, Canada., Lu D; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Shi R; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Rowbotham DA; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Becker-Santos DD; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Johnson FD; British Columbia Cancer Research Centre, Vancouver, BC, Canada., English JC; Vancouver General Hospital, Vancouver, BC, Canada., MacAulay CE; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Lam S; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Lockwood WW; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Chari R; Frederick National Lab for Cancer Research, Laboratory Animal Sciences Program, Frederick, MD, USA., Karsan A; British Columbia Cancer Research Centre, Vancouver, BC, Canada., Jurisica I; Krembil Research Institute, University Health Network, Toronto, ON, Canada., Lam WL; British Columbia Cancer Research Centre, Vancouver, BC, Canada. wanlam@bccrc.ca.
Publikováno v:
Nature communications [Nat Commun] 2019 Nov 28; Vol. 10 (1), pp. 5438. Date of Electronic Publication: 2019 Nov 28.
Autor:
Martinez VD; 1IWK Health CentreHalifax, Nova Scotia, Canada., Marshall EA; 2BC Cancer AgencyVancouver, British Columbia, Canadaand., Anderson C; 2BC Cancer AgencyVancouver, British Columbia, Canadaand., Ng KW; 2BC Cancer AgencyVancouver, British Columbia, Canadaand., Minatel BC; 2BC Cancer AgencyVancouver, British Columbia, Canadaand., Sage AP; 2BC Cancer AgencyVancouver, British Columbia, Canadaand., Enfield KSS; 2BC Cancer AgencyVancouver, British Columbia, Canadaand., Xu Z; 3Dalhousie UniversityHalifax, Nova Scotia, Canada., Lam WL; 2BC Cancer AgencyVancouver, British Columbia, Canadaand.
Publikováno v:
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2019 Aug; Vol. 61 (2), pp. 266-268.